A Study of the Natural Progression of Interstitial Lung Disease (ILD)

University of Chicago4,000 enrolled

Overview

We propose to acquire data and blood samples on all patients being cared for by the Interstitial Lung Disease (ILD) program. Additionally, we will collect data and blood samples from a control group for comparator purposes. In doing so, we will be able to describe the "phenotypic" expression of these diseases.

Study Type

OBSERVATIONAL

Enrollment

4,000

Conditions

Interstitial Lung Diseases Idiopathic Pulmonary Fibrosis Sarcoidosis Connective Tissue Disorder

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Interstitial lung disease Exclusion Criteria: * Does not have Interstitial lung disease

Locations (1)

University of Chicago

Chicago, Illinois, United States

RECRUITING

Outcomes

Primary Outcomes

Natural history of course of disease in patients with Interstitial lung disease (ILD)

We assess mortality roughly yearly but duration is unlimited

Time frame: Yearly

Central Contacts

Vanita Patel, MPH

CONTACT

773-702-1012

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.